Cogent Biosciences, Inc.COGTNASDAQ
Loading
Year-over-year earnings per share growth rate
5Y CAGR
-48.6%/yr
Long-term compound
Percentile
P68
Within normal range
vs 5Y Ago
0x
Contraction
Streak
2 qtr
Consecutive growthAccelerating
| Period | Value |
|---|---|
| Q4 2025 | 2.82% |
| Q3 2025 | -10.94% |
| Q2 2025 | -23.08% |
| Q1 2025 | 14.75% |
| Q4 2024 | 4.69% |
| Q3 2024 | -8.47% |
| Q2 2024 | 4.84% |
| Q1 2024 | 1.59% |
| Q4 2023 | 1.56% |
| Q3 2023 | -8.47% |
| Q2 2023 | -22.92% |
| Q1 2023 | 4.00% |
| Q4 2022 | -4.17% |
| Q3 2022 | 32.39% |
| Q2 2022 | -7.58% |
| Q1 2022 | -15.79% |
| Q4 2021 | -18.75% |
| Q3 2021 | -11.63% |
| Q2 2021 | -26.47% |
| Q1 2021 | 68.52% |
| Q4 2020 | 78.70% |
| Q3 2020 | -433.68% |
| Q2 2020 | -17.28% |
| Q1 2020 | -389.29% |
| Q4 2019 | 117.95% |
| Q3 2019 | -13.04% |
| Q2 2019 | 10.97% |
| Q1 2019 | -34.78% |
| Q4 2018 | 15.44% |
| Q3 2018 | -9.68% |
| Q2 2018 | -21.57% |
| Q1 2018 | 10.53% |
| Q4 2017 | 5.00% |
| Q3 2017 | -20.00% |
| Q2 2017 | 0.99% |
| Q1 2017 | 0.00% |
| Q3 2016 | 0.00% |
| Q3 2015 | 0.00% |